Christophe Aubert
Technik-/Wissenschafts-/F&E-Leiter bei MyoPowers Medical Technologies France SAS
Ursprung des Netzwerks ersten Grades von Christophe Aubert
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
MyoPowers Medical Technologies France SAS
 MyoPowers Medical Technologies France SAS Medical SpecialtiesHealth Technology MyoPowers Medical Technologies France SA operates as a medical device company. It specializes in muscle technologies to restore or improve muscle function. The firm also develops implantable medical devices for the treatment of severe stress urinary incontinence. The company was founded by Piergiorgio Tozzi and Daniel Hyoz in June 2004 and is headquartered in Lausanne, Switzerland.
6
| Subsidiary | Medical Specialties | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christophe Aubert
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| THERADIAG | Medical Specialties | Chief Executive Officer | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
| University of Fribourg | College/University | Corporate Officer/Principal | |
| University of Lausanne | College/University | Founder | |
| SYMETIS SA | Biotechnology | Founder | |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Founder | |
| Drugabuse Sciences, Inc. | Founder | ||
| Sangstat Pharmaceuticals Corp. | Founder | ||
| CARMAT | Medical Specialties | Founder | |
| PHARNEXT SCA | Biotechnology | Founder | |
| THERACLION | Medical Specialties | Director/Board Member | |
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Pharmaceuticals: Major | Founder | |
| VEXIM | Medical Specialties | Founder | |
| DEINOVE | Biotechnology | Founder | |
| The European Association for Bioindustries | Director/Board Member | ||
European Society For Clinical Investigation
 European Society For Clinical Investigation Miscellaneous Commercial ServicesCommercial Services The European Society for Clinical Investigation is a pan-European society established in 1967 with the goal of integrating clinicians and scientists interested in uncovering the mechanisms of disease. The private company is based in Utrecht, Netherlands. The society welcomes new members from all over and aims to be the leading clinical research society. Membership includes discussions, debates, and opportunities to meet colleagues in order to further the science of clinical investigation. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Conseil Stratégique pour l'Innovation | Chairman | ||
| Strategic Council on Business Attractiveness | Corporate Officer/Principal | ||
| Nakostech SARL | Corporate Officer/Principal | ||
| CARBIOS | Miscellaneous Commercial Services | Founder | |
Kardiozis SAS
 Kardiozis SAS Medical SpecialtiesHealth Technology Kardiozis SAS engages in radio diagnostic and radiotherapy activities. It also develops aortic stent. The company was founded on March 15, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Epygon SASU
 Epygon SASU Medical SpecialtiesHealth Technology Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
| Die Schweizerische Gesellschaft für Kardiologie | Corporate Officer/Principal | ||
Association Marie Lannelongue
 Association Marie Lannelongue Hospital/Nursing ManagementHealth Services Part of Le Groupe hospitalier Paris Saint-Joseph, Association Marie Lannelongue provides medical care services. The company is based in Le Plessis Robinson, France. Association Marie Lannelongue was acquired by Le Groupe hospitalier Paris Saint-Joseph on January 01, 2020. | Hospital/Nursing Management | Director/Board Member | |
| AFFLUENT MEDICAL | Medical Specialties | Founder Director/Board Member | |
Nanosive SASU
 Nanosive SASU Miscellaneous Commercial ServicesCommercial Services Nanosive SASU engages in research and development in other physical and natural sciences. The company was founded by Philippe Pouletty on December 20, 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Founder | |
| Artedrone SAS | Director/Board Member | ||
| Shanghai Myopowers Medical Technology Co. Ltd. | Director/Board Member | ||
| Société Suisse D’Angiologie | President | ||
| Myopowers Medical Technolgies SA, (Zweigniederlassung Basel) | Director/Board Member | ||
| Bmd SA | Chairman | ||
| Holistick Medical Sasu | Director/Board Member | ||
| Skinosive Sasu | Chairman | ||
| Pk Med SAS | Chairman | ||
| Caranx Medical SAS | Founder | ||
| Bariatek Medical SAS | Director/Board Member | ||
| Spikimm SAS | Chairman | ||
Plasmaprime SAS
 Plasmaprime SAS Medical/Nursing ServicesHealth Services Plasmaprime SAS provides plasma derived drugs collected from blood transfusion centers. The company was founded by Heriberto Sieler and Philippe Pouletty on January 23, 2009 and is headquartered in Evry, France. | Medical/Nursing Services | Founder | |
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder |
Statistik
International
| Frankreich | 37 |
| Schweiz | 7 |
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 22 |
| Commercial Services | 5 |
| Health Services | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 41 |
| Founder | 23 |
| Chairman | 15 |
| Corporate Officer/Principal | 9 |
| Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Daniel Hayoz | 7 |
| Bau Georges | 2 |
| Pierre Costa | 2 |
| Roland Dahlem | 1 |
| Carlos Smet | 1 |
- Börse
- Insiders
- Christophe Aubert
- Unternehmensverbindungen